Friday, January 5, 2018

01/03/2018AuroMedics Pharma LLC  Ampicillin and Sulbactam for Injection USP  Presence of glass particlesAuroMedics Pharma LLC

Must Read! Compounding experts do not expect FDA to let up on the gas in 2018 on implementing the Drug Quality and Security Act,

Stakeholders Expect Flurry Of Compounding Action, Hope For ...

Inside Health Policy-8 hours ago
Compounding experts do not expect FDA to let up on the gas in 2018 on implementing the Drug Quality and Security Act, but many experts hope the agency will rethink what some see as its initial missteps in implementing the compounding law, including a perceived overly lax bar for compounding bulk substances and ...

FDA aims to strengthen oversight of compounded drug manufacturing
The Food and Drug Administration aims to "reinvigorate" efforts to improve production standards for compounded drug products, highlighting continued safety concerns with the industry practice in a recent update published in the New England Journal of Medicine. Since a deadly meningitis outbreak in .

IACP announced that TherapeuticsMD will no longer be an IACP corporate member.


International Academy of Compounding Pharmacists Announcement
HOUSTON, Jan. 5, 2018 /PRNewswire/ -- The International Academy of Compounding Pharmacists (IACP), representing nearly 4,000 pharmacists, technicians, students and members of the compounding community who focus upon the specialty practice of pharmacy compounding, today announced 

Thursday, January 4, 2018

ß
Ogletree, Deakins, Nash, Smoak & Stewart
2017 has been quite a year, with ever-changing regulations, trends, and employee expectations at the local, state, and federal levels. In this environment of constant flux, an outdated ...
ß
Withers LLP
Section 4960 imposes an excise tax on tax-exempt employers.

FDA warns American CryoStem Corporation of significant deviations related to its unapproved stem cell product, Atcell


The U.S. Food and Drug Administration today posted a warning letter issued to American CryoStem Corporation of Monmouth Junction, New Jersey, and its Chairman/Chief Executive Officer, John S. Arnone, for marketing an adipose derived stem cell product without FDA approval and for significant deviations from current good manufacturing practice requirements, including some that raise potential significant safety concerns, putting patients at risk. Continue reading.

What Will Happen If Amazon Gets Into the Prescription Drug ...

Healthline-16 hours ago
Morgan Stanley estimates that mail-order prescriptions account for about $106 billion of the $465 billion U.S. pharmaceutical business. Amazon's entry into this market would boost the company's bottom line. But if and when Amazon opens up an online pharmacy, it will find the market dominated by Walgreens, CVS Health,

North Texas pharmacies struggling to keep Tamiflu in stock

FOX 4 News-10 hours ago
Pharmacies across North Texas are struggling to keep Tamiflu in stock as the flu season hits hard. The CD recently identified Texas as having one of the largest spikes in flu cases in the country. One of the largest pharmacies in Tarrant county almost ran out of Tamiflu last week. And one emergency room is even increasing ...

Chicago Acts to Address Pharmacist Workload and Patient Safety

Pharmacy Times-26 minutes ago
Many have decried that prescription errors are relat-ed to the increasing pressure facing pharmacists to fill more prescriptions. Additionally, pharmacists are asked to provide services such as vaccinations, adher-ence calls, and other ancillary activities. Recently, NBC 5 in Chicago, Illinois, reported that pharmacy metrics ...

Pressure's On CVS As Walgreens US Pharmacy Sales Rise

Forbes-19 minutes ago
Buoyed by new pharmacy partnerships to drive prescriptions through its stores, Walgreens Boots Alliance Thursday reported improved U.S. drugstore revenue at the expense of its chief rival, CVS Health. On Thursday, Walgreens, the U.S. largest drugstore chain, said fiscal 2018 first quarter net earnings were down 22% to ...

Wednesday, January 3, 2018

California State Board of Pharmacy Meeting Agenda for January 11, 2018

January 11, 2018
Webcast
California Northstate University – Event Center
9650 West Taron Drive
Elk Grove, CA 95757
Agenda

California State Board of Pharmacy New Laws for 2018

California State Board of Pharmacy New Laws for 2018

Alaska Board of Pharmacy November 30, 2017 Minutes from Meeting

Alabama Board of Pharmacy Meeting Scheduled for January 23-24, 2018

January 23 - 24, 2018 

Louisiana Board of Pharmacy January 2018 Newsletter

North Carolina Board of Pharmacy January 2018 Newsletter

High Importance from the Oklahoma Board of Pharmacy

From the Inspector’s Desk ♦ 18.01. Nonsterile Compounding: A retail pharmacy may no longer provide any nonsterile compounds to physicians for “office use.” ♦ 18.02. CDS Invoices: When receiving controlled dangerous substances (CDS) from the wholesale distributor, the person checking in the drugs must either circle the quantity received for each drug, place a check mark by the quantity received for each drug, or make a notation that all drugs were received. ♦ 18.03. Compounding in Anticipation of a Prescription: Per Drug Enforcement Administration (DEA), a retail pharmacy cannot prepare in anticipation more than a 30- day supply of a compounded preparation containing a CDS. ♦ 18.04. CDS Prescriptions: In Oklahoma, a physician cannot issue multiple prescriptions to a patient for the same drug. DEA allows this, but the Oklahoma Bureau of Narcotics and Dangerous Drugs does not have a corresponding law or rule that allows it in Oklahoma. It is illegal for a prescriber to postdate a prescription. All CDS prescriptions must be dated and signed on the day when issued. If a prescriber does not want the patient to fill it that day, then he or she can put instructions on the prescription as to the date when it can be filled. The date to be filled should not exceed 30 days from the date written for Schedule II prescriptions. ♦ 18.05. BUDs for Nonsterile Compounded Preparations: For water-containing or aqueous-based topical/dermal and mucosal liquid and semisolid formations, the beyond-use date (BUD) may not exceed 30 days. For aqueous-based oral formulations, the BUD may not be longer than 14 days when stored under refrigeration. Even when you add an active pharmaceutical ingredient (API) to a commercial  product that has an aqueous component, the BUD should not exceed 14 days when refrigerated. For non-aqueous formulations, the BUD may not exceed the earliest expiration date of any API or six months, whichever is earlier. Watch the expiration dates for all ingredients used, including inactive ingredients. The BUD cannot exceed the expiration date of any ingredient used in compounding the preparation. The USP standards listed above may be exceeded when there is supporting scientific stability information that is directly applicable to the specific preparation (eg, the same drug, same brands, concentration range, pH, excipients, vehicle, water content). ♦ 18.06. Topical Compounds in Syringes Labeled “For Oral Use”: Please do not dispense topical compounded products in syringes labeled “for oral use” unless you have covered or removed the words “for oral use.” The Board has received reports of patients receiving topical medications by mouth, particularly when the person administering the medication is not the same as the person who received counseling on the prescription. ♦ 18.07. BUD for Repackaged Drugs: Food and Drug Administration (FDA) recently released a repackaging guidance that changes the acceptable expiration date for repackaged medications. The guidance applies to FDAregistered repackaging firms that are repackaging solid oral dosage forms into unit-dose containers. It does not apply to solid oral dosage forms repackaged by state-licensed pharmacies, nor to other dosage forms (sterile, liquid, or topical). Retail and hospital pharmacies that repackage into unit dose for use within their own hospital are exempt and may continue to use a one-year expiration date or the manufacturer’s expiration date, if it is less than one year. ♦ 18.08. CBD Oil: According to the Oklahoma Bureau of Narcotics, cannabidiol (CBD) oil with any detectable amount of delta-9 tetrahydrocannabinol (THC) is not legal to sell. It is extremely difficult, if not impossible, to remove all THC from a natural source of CBD oil. Synthetic CBD oil is permitted if there is no detectable quantity of THC. The Board recommends that if a pharmacy chooses to sell CBD oil, the pharmacy should obtain a certificate of analysis or have the product independently tested for the presence and quantity of THC. There have been many reports of products that have purported to contain no THC, but have tested otherwise. Pharmacies dispensing CBD products containing no more than 0.3% THC must be enrolled in an FDA-approved clinical trial. In order for a person aged 18 years or younger to receive CBD containing no more than 0.3% THC, he or she must either be participating in a clinical trial or receive a written certification from a physician licensed in this state as having been diagnosed with Lennox-Gaustaut syndrome; Dravet syndrome, also known as severe myoclonic epilepsy of infancy, or any other severe form of epilepsy that is not adequately treated by traditional therapies; spasticity due to multiple sclerosis or paraplegia; intractable nausea and vomiting; or appetite stimulation with chronic wasting diseases. The CBD must be delivered to the patient in the form of a liquid. Pursuant to Oklahoma Statutes Title 63, Section 2-101, industrial hemp from the plant Cannabis sativa L. and any part of such plant, whether growing or not, with a THC concentration of not more than three-tenths of one percent (0.3%) on a dry weight basis shall not be grown anywhere in the state of Oklahoma but may be shipped to Oklahoma. ♦ 18.09. Clarification of Transferring “On-Hold” CDS Prescriptions: DEA has issued a statement allowing pharmacies to transfer “on-hold” Schedule II-V electronic prescriptions from one pharmacy to another if they had not been filled at the original pharmacy. However, DEA requires the transfer to be done electronically, and the electronic prescriptions for controlled substances (EPCS) software does not permit pharmacies to transmit prescriptions from one pharmacy to another. Fax transmittal is not considered to be electronic transmission. If software is changed to accommodate the requirements of EPCS, then “on-hold” CDS prescriptions may be transferred between pharmacies. DEA does not permit pharmacies to transfer “on-hold” CDS prescriptions that have been received by any other means of communication, including facsimile, verbal, or written. These requirements do not apply to the transfer of refills of CDS prescriptions. Refills may be transferred as per Oklahoma Administrative Code 535:15-3-12 and 535:15- 3-12.1.

quoted from the January 2018 Oklahoma Board of Pharmacy Newsletter

Oklahoma Board of Pharmacy January 2018 Newsletter

South Dakota State Board of Pharmacy January 2018 Newsletter

Statement from FDA Commissioner Scott Gottlieb, MD on new steps ...

FDA.gov-7 hours ago
The FDA today announced additional steps to encourage generic competition as part of our continued implementation of the Drug Competition Action Plan. This plan has three main components: reducing gaming by branded companies that can delay generic drug entry; resolving scientific and regulatory obstacles that can ...

How Will the Supplement Industry Fare without Hatch?

MedPage Today-59 minutes ago
Orrin Hatch (R-Utah), the supplement industry may have to look for a new champion. Hatch, the longest serving Republican in the Senate, announced plans to retire in early 2019, according to the Salt Lake Tribune. He was one of the primary authors and "the moving force" behind the Dietary Supplement Health and .

Sen. Hatch to Retire, Leaving Void for Dietary Supplement Industry

Natural Products INSIDER (blog)-6 hours ago
It was Hatch who co-authored the Dietary Supplement Health and Education Act of 1994 (DSHEA). Since the passage of DSHEA, the industry has grown exponentially with tens of billions of dollars in annual sales. And over the years as critics have questioned the regulatory framework governing supplements, Hatch has ...

Critics Say FIFA Is Stalling a Doping Inquiry as World Cup Nears

New York Times-10 hours ago
With the Russia World Cup six months away, leaders of the antidoping movement are criticizing soccer's governing body over its failure to pursue more aggressively whether Russian authorities covered up positive doping tests belonging to the country's top soccer players. Travis Tygart, the head of the United States ...
Rodchenkov free to provide evidence to FIFA
Insidethegames.biz (blog)-6 hours ago

Do Formulary Lists Reduce Patient Access to Prescription Drugs?

Specialty Pharmacy Times-6 hours ago
Formulary lists are used by pharmacy benefit managers (PBMs) to control costs and prevent unnecessary drug spending by incentivizing the use of lower cost and generic medications over costlier branded products. PBMs say this practice reduces overall spending on prescription drugs and helps patients lower their ...

4 Things Pharmacists Should Know About the Shingrix Vaccine

Pharmacy Times-1 hour ago
Shingrix (Zoster Vaccine Recombinant, Adjuvanted) was approved in October 2017 for adults 50 and older for the prevention of shingles, a viral infection that causes a painful rash that generally develops on 1 side of the body, usually the face or torso. The risk of shingles and post-herpetic neuralgia (PHN) increases with ...

HEE outlines future workforce strategy for pharmacy

The Pharmaceutical Journal-11 hours ago
It said it aimed to “future proof” the NHS workforce, and while it acknowledged the role of pharmacy in new models of care and workforce programmes outlined in the NHS Five Year Forward View, there was no commitment to new strategies or funding for the sector. The Royal Pharmaceutical Society welcomed the ..

US District Court Rules Against 340B Hospitals

Pharmacy Practice News-4 hours ago
... program allows participating hospitals to use the savings from the discounts to provide an expanded range of comprehensive health services to their local communities, such as increased access to care, clinical pharmacy services, community outreach programs, free vaccines and transportation to follow-up appointments.

Are Canadian Pharmacies the Solution to America's High ...

Reason (blog)-4 hours ago
pharmacy in Toronto, where all the good cheap drugs are. Photo credit: Rene Johnston Toronto Star/ZUMA Press/NewscomEvery day for the last three years, I've started my morning with four prescription pills that cost roughly $11 each. I say "roughly" because the price fluctuates. The last time I filled a 90-day prescription, ...

FDA revokes draft compounding guidance
The new guidance will replace the draft document "Compounding Animal Drugs from Bulk Drug Substances," which was published in May 2015. It described FDA interpretations of the legality of compounding animal drugs from bulk pharmaceutical substances and indicated when the FDA would ...
Seven key changes the new tax law will force hospitals to consider
The Tax Cuts and Jobs Act will force not-for-profit hospitals to grapple with changes that make their tax-exempt status less advantageous, including new provisions on unrelated business taxable income and executive compensation.  READ MORE

FDA Law Blog: FDA Issues Final Guidance on Additive Manufactured (“3D-Printed”) Devices Posted: 02 Jan 2018 06:37 PM PST By Rachel E. Hunt & Allyson B. Mullen —

Tuesday, January 2, 2018

11/30/2017TruVision Health LLCDenver District OfficeCGMP/Finished Pharmaceuticals/Adulterated/Unapproved New DrugNot Issued *
12/18/2017Fresenius Kabi Oncology Limited (Baddi)Center for Drug Evaluation and ResearchCGMP/Finished Pharmaceuticals/AdulteratedNot Issued *
12/18/2017Prosana Distribuciones SA de CVCenter for Drug Evaluation and ResearchCGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug/MisbrandedNot Issued *
12/18/2017Prosana Distribuciones SA de CVCenter for Drug Evaluation and ResearchCGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug/MisbrandedNot Issued *

Monday, January 1, 2018

Innovations – NABP’s Newsletter January 2018 and 2018 Index

Doping In Sports - Cheating Or Leveling Of The Playing Field?

Forbes-Dec 31, 2017
On December 5, 2017, the International Olympic Committee (IOC) banned Russia from taking the national team to the February 2018 winter games in Pyeongchang, South Korea. This decision was a punishment for running a state-sponsored dopingprogram. If Russian athletes independently prove they are clean, they can ...

State of California Office of Administrative Law Approves Emergency Compounding Regulation Package - International Academy of Compounding Pharmacists

State of California Office of Administrative Law Approves Emergency Compounding Regulation Package - International Academy of Compounding Pharmacists

Nevada State Board of Pharmacy Notice of Intent to Act Upon A Regulation

01/11/2018    9:00AM 
Meeting Notice
Nevada State Board of Pharmacy 
Notice of Intent to Act Upon a Regulation
Hilton Garden Inn - 7830 South Las Vegas Blvd. - Las Vegas, NV 

Nevada State Board of Pharmacy Regulation Workshop

01/11/2018    9:00AM 
Meeting Notice
Nevada State Board of Pharmacy 
Regulation Workshop
Hilton Garden Inn - 7830 S. Las Vegas Blvd. - Las Vegas, NV

Iowa Board of Pharmacy Notices of Intended Action proposing amendments to various Board Rules

Date: 
Tuesday, December 26, 2017
The Board of Pharmacy has filed Notices of Intended Action (NOIA) proposing amendments to various Board rules. The Board is soliciting comments and suggestions regarding those proposed amendments. 
The NOIAs are available at https://rules.iowa.gov/ and comments can be submitted directly through the NOIA -- follow the prompts on the website. Comments may also be submitted via mail or email as identified in the NOIA. 
The following ARC numbers identify the NOIAs that are currently available for comment. Comments are due not later than 4:30 p.m. on January 19, 2018.
ARC 3505C
ARC 3506C
ARC 3507C
ARC 3508C
ARC 3509C
ARC 3510C
ARC 3511C
ARC 3512C
The Board also adopted previously proposed amendments to 657 Chapter 16, Nuclear Pharmacy Practice. The amendments will become effective January 24, 2018, and are available on the same Rules website as ARC 3525C.

On November 28, 2017, the Pennsylvania State Board of ... - St. Louis

www.stltoday.com/...state-board-of-pharmacy/ad_c902cbb9-802f-5f59-a5e4-dcaf929...
6 days ago - On November 28, 2017, the Pennsylvania State Board of Pharmacy accepted the voluntary surrender of Daniel Allen Brust, license no. RP442336, of O'Fallon, Missouri, because he had a lic

FDA bans triclosan, 23 other antiseptic ingredients

Pharmacy Today, American Pharmacists Association, pharmacist.com-Dec 28, 2017
FDA has finalized a rule banning the marketing of OTC healthcare antiseptic products containing triclosan or any of 23 other active ingredients, having found these ingredients are not generally recognized as safe and effective (GRASE). FDA has finalized a rule banning the marketing of OTC healthcare antiseptic products .

Theranos gets $100 million lifeline from Fortress

Pharmacy Today, American Pharmacists Association, pharmacist.com-Dec 28, 2017
The blood-testing company Theranos Inc. told its investors this week that it has secured a $100 million loan from Fortress Investment Group LLC, averting for now a possible bankruptcy filing as its remaining cash dwindled. The blood-testing company Theranos Inc. told its investors this week that it has secured a $100 ...

Appeals court asked to rule on pharmacy slaying conviction

Tulsa World-Dec 30, 2017
Former pharmacist Jerome Jay Ersland is taking his last-ditch challenge of his murder conviction to the federal appeals court in Denver. Ersland, 66, is serving a life sentence for fatally shooting an unarmed, already wounded teenage robber in 2009 inside an Oklahoma City pharmacy. He is not eligible for parole until 2049.

Pharmacists slow to dispense lifesaving overdose drug

WBIR-TV-Dec 30, 2017
Gale Dunham, a pharmacist in Calistoga, Calif., knows the devastation the opioid epidemic has wrought, and she is glad the anti-overdose drug naloxone is becoming more accessible. But Dunham said that so far, she has not taken advantage of a California law that allows pharmacists to dispense the medication to ...

All My Pharmacy Students Learn to Code

Pharmacy Times-Dec 27, 2017
We all know that health care is changing rapidly. The mobile phone, augmented by health and wellness trackers, apps, and sensors is shifting care into the home. Pharmacists must be leading new practice model initiatives and, at a minimum, be familiar with connected technology. The chief clinical officer of Partners 

For Pharmacist Turned CEO: CVS' Larry Merlo Faces Biggest ...

Hartford Courant-Dec 31, 2017
When Larry J. Merlo took the CEO job at CVS in 2011, some wondered if his experience heading the drugstore chain's retail operations had prepared him enough to tackle CVS's strategic transition into a health care company. But since assuming the helm, Merlo steadied a faltering merger with pharmacy benefits manager ..

New Nevada law aims to tackle opioid epidemic

Las Vegas Review-Journal-9 hours ago
The Prescription Drug Abuse Prevention Act, passed by the 2017 Legislature, outlines safeguards for doctors before they prescribe controlled substances to treat pain and increases requirements ... At 27, Wells injured his spinal cord while snowboarding, an injury compounded by an unnecessary surgery years later.